Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan J Clark

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The Lancet. Microbe|June 2, 2025
Mapping of human monoclonal antibody responses to XBB.1.5 COVID-19 monovalent vaccines: a B cell analysisRaianna F Fantin, Jordan J Clark, Hallie Cohn, et al.
Nature|January 11, 2022
Activity of convalescent and vaccine serum against SARS-CoV-2 OmicronJuan Manuel Carreño, Hala Alshammary, Johnstone Tcheou, et al.
The Lancet. Infectious Diseases|July 20, 2023
Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational studyHallie Cohn, Nathaniel Bloom, Gianna Y Cai, et al.
Viruses|June 27, 2024
Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19Jordan J Clark, Rebekah Penrice-Randal, Parul Sharma, et al.
Plos Neglected Tropical Diseases|October 6, 2016
Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika Virus from Recife, BrazilClaire L Donald, Benjamin Brennan, Stephanie L Cumberworth, et al.
Frontiers in Immunology|October 30, 2024
Pulmonary SARS-CoV-2 infection leads to para-infectious immune activation in the brainCordelia Dunai, Claire Hetherington, Sarah A Boardman, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 22, 2024
The IRE1α-XBP1 arm of the unfolded protein response is a host factor activated in SARS-CoV-2 infectionJose Javier Fernández, Arturo Marín, Romel Rosales, et al.
Cell|August 27, 2025
Human monoclonal antibodies targeting A35 protect from death caused by mpoxRaianna F Fantin, Meng Yuan, Seok-Chan Park, et al.
Nature Communications|September 23, 2021
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19Jiandong Huo, Halina Mikolajek, Audrey Le Bas, et al.
ACS Medicinal Chemistry Letters|April 15, 2026
DNA-Encoded Library (DEL) Selection Identifies a Distinct DDB1 Ligand Binding SiteShiva Krishna Reddy Guduru, John P Caldwell, Katherine M Digianantonio, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Lancet. Microbe|June 2, 2025
Mapping of human monoclonal antibody responses to XBB.1.5 COVID-19 monovalent vaccines: a B cell analysisRaianna F Fantin, Jordan J Clark, Hallie Cohn, et al.
Nature|January 11, 2022
Activity of convalescent and vaccine serum against SARS-CoV-2 OmicronJuan Manuel Carreño, Hala Alshammary, Johnstone Tcheou, et al.
The Lancet. Infectious Diseases|July 20, 2023
Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational studyHallie Cohn, Nathaniel Bloom, Gianna Y Cai, et al.
Viruses|June 27, 2024
Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19Jordan J Clark, Rebekah Penrice-Randal, Parul Sharma, et al.
Plos Neglected Tropical Diseases|October 6, 2016
Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika Virus from Recife, BrazilClaire L Donald, Benjamin Brennan, Stephanie L Cumberworth, et al.
Frontiers in Immunology|October 30, 2024
Pulmonary SARS-CoV-2 infection leads to para-infectious immune activation in the brainCordelia Dunai, Claire Hetherington, Sarah A Boardman, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 22, 2024
The IRE1α-XBP1 arm of the unfolded protein response is a host factor activated in SARS-CoV-2 infectionJose Javier Fernández, Arturo Marín, Romel Rosales, et al.
Cell|August 27, 2025
Human monoclonal antibodies targeting A35 protect from death caused by mpoxRaianna F Fantin, Meng Yuan, Seok-Chan Park, et al.
Nature Communications|September 23, 2021
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19Jiandong Huo, Halina Mikolajek, Audrey Le Bas, et al.
ACS Medicinal Chemistry Letters|April 15, 2026
DNA-Encoded Library (DEL) Selection Identifies a Distinct DDB1 Ligand Binding SiteShiva Krishna Reddy Guduru, John P Caldwell, Katherine M Digianantonio, et al.
Pageof 4